AtriCure, Inc. (ATRC)
58.97
-0.33
(-0.56%)
USD |
NASDAQ |
Oct 23, 16:00
58.99
+0.02
(+0.03%)
Pre-Market: 20:00
AtriCure Price to Book Value : 5.808 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.808 |
| October 22, 2026 | 5.840 |
| October 21, 2026 | 5.680 |
| October 20, 2026 | 5.680 |
| October 19, 2026 | 5.469 |
| October 16, 2026 | 5.522 |
| October 15, 2026 | 5.691 |
| October 14, 2026 | 5.643 |
| October 13, 2026 | 5.601 |
| October 12, 2026 | 5.642 |
| October 09, 2026 | 5.497 |
| October 08, 2026 | 5.204 |
| October 07, 2026 | 5.250 |
| October 06, 2026 | 5.287 |
| October 05, 2026 | 5.552 |
| October 02, 2026 | 5.431 |
| October 01, 2026 | 5.278 |
| September 30, 2026 | 5.535 |
| September 29, 2026 | 5.717 |
| September 28, 2026 | 5.753 |
| September 25, 2026 | 5.750 |
| September 24, 2026 | 5.985 |
| September 23, 2026 | 5.905 |
| September 22, 2026 | 5.794 |
| September 21, 2026 | 5.744 |
| Date | Value |
|---|---|
| September 18, 2026 | 5.722 |
| September 17, 2026 | 5.823 |
| September 16, 2026 | 5.628 |
| September 15, 2026 | 5.537 |
| September 14, 2026 | 5.495 |
| September 11, 2026 | 5.372 |
| September 10, 2026 | 5.216 |
| September 09, 2026 | 5.223 |
| September 08, 2026 | 5.292 |
| September 04, 2026 | 5.074 |
| September 03, 2026 | 5.167 |
| September 02, 2026 | 5.180 |
| September 01, 2026 | 4.818 |
| August 31, 2026 | 4.762 |
| August 28, 2026 | 4.781 |
| August 27, 2026 | 4.853 |
| August 26, 2026 | 4.744 |
| August 25, 2026 | 4.794 |
| August 24, 2026 | 4.854 |
| August 21, 2026 | 4.824 |
| August 20, 2026 | 4.677 |
| August 19, 2026 | 4.689 |
| August 18, 2026 | 4.507 |
| August 17, 2026 | 4.409 |
| August 14, 2026 | 4.363 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Abbott Laboratories | 3.511 |
| Boston Scientific Corp. | 2.651 |
| AngioDynamics, Inc. | 3.199 |
| Alphatec Holdings, Inc. | -- |
| Baxter International, Inc. | 2.108 |
Price to Book Value Related Metrics
| PE Ratio | 272.50 |
| PS Ratio | 5.016 |
| Price to Free Cash Flow | 53.79 |
| Price | 58.97 |
| Earnings Yield | 0.37% |
| Market Cap | 2.999B |
| Operating PE Ratio | 205.69 |
| Normalized PE Ratio | 255.17 |